全文获取类型
收费全文 | 47380篇 |
免费 | 3402篇 |
国内免费 | 190篇 |
专业分类
耳鼻咽喉 | 380篇 |
儿科学 | 1534篇 |
妇产科学 | 1225篇 |
基础医学 | 6675篇 |
口腔科学 | 591篇 |
临床医学 | 5102篇 |
内科学 | 9915篇 |
皮肤病学 | 889篇 |
神经病学 | 5570篇 |
特种医学 | 1133篇 |
外科学 | 4210篇 |
综合类 | 399篇 |
一般理论 | 58篇 |
预防医学 | 5762篇 |
眼科学 | 636篇 |
药学 | 2998篇 |
中国医学 | 87篇 |
肿瘤学 | 3808篇 |
出版年
2024年 | 59篇 |
2023年 | 653篇 |
2022年 | 1089篇 |
2021年 | 2151篇 |
2020年 | 1306篇 |
2019年 | 1780篇 |
2018年 | 2041篇 |
2017年 | 1363篇 |
2016年 | 1521篇 |
2015年 | 1671篇 |
2014年 | 2033篇 |
2013年 | 2640篇 |
2012年 | 4204篇 |
2011年 | 4173篇 |
2010年 | 2115篇 |
2009年 | 1853篇 |
2008年 | 2965篇 |
2007年 | 2925篇 |
2006年 | 2802篇 |
2005年 | 2597篇 |
2004年 | 2306篇 |
2003年 | 2057篇 |
2002年 | 1760篇 |
2001年 | 214篇 |
2000年 | 182篇 |
1999年 | 224篇 |
1998年 | 360篇 |
1997年 | 269篇 |
1996年 | 223篇 |
1995年 | 188篇 |
1994年 | 138篇 |
1993年 | 132篇 |
1992年 | 88篇 |
1991年 | 86篇 |
1990年 | 76篇 |
1989年 | 82篇 |
1988年 | 77篇 |
1987年 | 53篇 |
1986年 | 65篇 |
1985年 | 60篇 |
1984年 | 67篇 |
1983年 | 63篇 |
1982年 | 37篇 |
1981年 | 46篇 |
1980年 | 35篇 |
1979年 | 27篇 |
1978年 | 20篇 |
1977年 | 23篇 |
1976年 | 11篇 |
1975年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 10 毫秒
11.
Danail Hristozov Alex Zabeo Keld Alstrup Jensen Stefania Gottardo Panagiotis Isigonis Laura Maccalman 《Nanotoxicology》2016,10(9):1215-1228
Several tools to facilitate the risk assessment and management of manufactured nanomaterials (MN) have been developed. Most of them require input data on physicochemical properties, toxicity and scenario-specific exposure information. However, such data are yet not readily available, and tools that can handle data gaps in a structured way to ensure transparent risk analysis for industrial and regulatory decision making are needed. This paper proposes such a quantitative risk prioritisation tool, based on a multi-criteria decision analysis algorithm, which combines advanced exposure and dose-response modelling to calculate margins of exposure (MoE) for a number of MN in order to rank their occupational risks. We demonstrated the tool in a number of workplace exposure scenarios (ES) involving the production and handling of nanoscale titanium dioxide, zinc oxide (ZnO), silver and multi-walled carbon nanotubes. The results of this application demonstrated that bag/bin filling, manual un/loading and dumping of large amounts of dry powders led to high emissions, which resulted in high risk associated with these ES. The ZnO MN revealed considerable hazard potential in vivo, which significantly influenced the risk prioritisation results. In order to study how variations in the input data affect our results, we performed probabilistic Monte Carlo sensitivity/uncertainty analysis, which demonstrated that the performance of the proposed model is stable against changes in the exposure and hazard input variables. 相似文献
12.
13.
14.
Marco Maruzzo Umberto Basso Eugenio Borsatti Laura Evangelista Filippo Alongi Orazio Caffo Francesca Maines Sara Galuppo Rocco De Vivo Fable Zustovich Dario Palleschi Andrea Zivi Teodoro Sava Mariella Sorarù Roberto Iacovelli Maurizio Nicodemo Susanne Baier Lucia Fratino Vittorina Zagonel 《Clinical genitourinary cancer》2019,17(1):e187-e194
Background
Radium 223 was introduced for metastatic castration-resistant prostate cancer based on the results of a randomized controlled trial showing risk reduction for death and skeletal events. Our aim was to evaluate the outcome of patients receiving radium 223 in a real-world setting.Patients and Methods
We conducted a multicenter retrospective analysis in the Triveneto region of Italy.Results
One hundred fifty-eight patients received radium 223 in our region. After a median follow-up of 9.5 months, 75 patients died. The median overall survival (OS) was 14.2 months, and the median progression-free survival (PFS) was 6.2 months. Seventy-one (45%) patients achieved progression as best response. Thirty-seven (23%) patients stopped the treatment early because of progression. Eastern Cooperative Oncology Group performance status was prognostic for OS (18.4 vs. 12.3 vs. 7.5 months; 0 vs. 1, P = .0062; 0 vs. 2, P = .0002), whereas previous prostatectomy or docetaxel exposure were not. A neutrophil to lymphocytes ratio ≥ 3 significantly impacted OS (18.1 vs. 9.7 months; P < .001) and slightly impacted PFS (6.6 vs. 5.6 months; P = .05). Patients with a baseline alkaline phosphatase (ALP) value ≥ 220 U/L had worse OS and PFS (24.1 vs. 10.5 months; 7.2 vs. 5.5 months; P < .001). Patients with changes in ALP value achieved better OS (P = .029) and PFS (P = .002). There was no difference according to the line of therapy (0 vs. ≥ 1; P = .490). The main grade 3/4 toxicities were anemia, asthenia, and thrombocytopenia.Conclusion
This large real-world report confirms comparable OS and PFS data when compared with the pivotal study, as well as the predictive role of ALP and neutrophil to lymphocytes ratio. The definition of the optimal position of radium 223 in the treatment of metastatic castration-resistant prostate cancer has still to be defined. 相似文献15.
16.
17.
Martina A. Steurer Jean Costello Rebecca J. Baer Scott P. Oltman Sky K. Feuer Tania Pacheco-Werner Elizabeth Rogers Marta M. Jankowska Jessica Block Molly McCarthy Matthew S. Pantell Christina Chambers Kelli K. Ryckman Laura L. Jelliffe-Pawlowski 《Paediatric and perinatal epidemiology》2020,34(2):130-138
18.
19.
20.
Spinal cord stimulation (SCS) is widely used for pain relief in patients with failed back surgery syndrome (FBSS), and muscle weakness is a common finding in patients with chronic pain. We present here a single case report of a 47‐year‐old woman, who, after SCS for FBSS, had continuous improvement in lower leg muscle strength and gait, but only transient and minimal pain relief. To the authors’ knowledge, this is only the second published case report of significant improvement in “motor” function, independent of the analgesic effect following SCS in FBSS. If SCS, in fact, does improve muscle strength, new strategies for the management of patients with chronic pain might be opened up. Further studies are needed to verify this hypothesis. 相似文献